These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27645199)

  • 1. Paying for antiretroviral adherence: is it unethical when the patient is an adolescent?
    Healy J; Hope R; Bhabha J; Eyal N
    J Med Ethics; 2017 Mar; 43(3):145-149. PubMed ID: 27645199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paid protection? Ethics of incentivised long-acting reversible contraception in adolescents with alcohol and other drug use.
    Won T; Blumenthal-Barby J; Chacko M
    J Med Ethics; 2017 Mar; 43(3):182-187. PubMed ID: 27178535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Children will always be children': exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell.
    Kawuma R; Bernays S; Siu G; Rhodes T; Seeley J
    Afr J AIDS Res; 2014; 13(2):189-95. PubMed ID: 25174636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
    Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
    Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa.
    Dahourou DL; Leroy V
    Med Mal Infect; 2017 Dec; 47(8):511-518. PubMed ID: 28943171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa.
    Cluver LD; Hodes RJ; Toska E; Kidia KK; Orkin FM; Sherr L; Meinck F
    AIDS; 2015 Jun; 29 Suppl 1():S57-65. PubMed ID: 26049539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
    Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
    AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Payment by Results"--financial incentives and motivational interviewing, adherence interventions in young adults with perinatally acquired HIV-1 infection: a pilot program.
    Foster C; McDonald S; Frize G; Ayers S; Fidler S
    AIDS Patient Care STDS; 2014 Jan; 28(1):28-32. PubMed ID: 24428797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.
    Rosen S; Fox MP; Larson BA; Sow PS; Ehrenkranz PD; Venter F; Manabe YC; Kaplan J;
    PLoS Med; 2016 Aug; 13(8):e1002106. PubMed ID: 27505444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food supplementation among HIV-infected adults in Sub-Saharan Africa: impact on treatment adherence and weight gain.
    Audain KA; Zotor FB; Amuna P; Ellahi B
    Proc Nutr Soc; 2015 Nov; 74(4):517-25. PubMed ID: 25761769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ' … But i'm still tired': the experience of fatigue among South African adolescents receiving antiretroviral therapy.
    Loades ME; Coetzee B; Du Toit S; Kagee A
    AIDS Care; 2018 Jun; 30(6):746-750. PubMed ID: 29067820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.
    Uthman RT; Sutton AJ; Jackson LJ; Uthman OA
    PLoS One; 2018; 13(1):e0191465. PubMed ID: 29360841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Too poor to say no? Health incentives for disadvantaged populations.
    Voigt K
    J Med Ethics; 2017 Mar; 43(3):162-166. PubMed ID: 27354248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.